Localization of aristolochic acid in mouse kidney tissues by immunohistochemistry using an anti-AA-I and AA-II monoclonal antibody

American Journal of Chinese Medicine

Volumn 42, Issue 6, 2014, Pages 1453-1469

  Li, Xiao Wei ^a   Yokota, Sadaki ^b   Wang, Dan ^a   Wang, Xuan ^a   Shoyama, Yukihiro ^b   Cai, Shao Qing ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b NAGASAKI INTERNATIONAL UNIVERSITY   (Japan)

Author keywords

Aristolochic Acid; Immunoelectron Microscopy; Immunoperoxidase Light Microscopy; Immunostaining; Kidney; Monoclonal Antibody

Indexed keywords

ARISTOLOCHIC ACID; ARISTOLOCHIC ACID 1; ARISTOLOCHIC ACID 2; COLLOIDAL GOLD; MONOCLONAL ANTIBODY; PARAFFIN; PEROXIDASE; UNCLASSIFIED DRUG; ANTIBODIES, MONOCLONAL; ARISTOLOCHIC ACID I; ARISTOLOCHIC ACIDS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DISTRIBUTION; ERYTHROCYTE; GLOMERULUS; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; KIDNEY COLLECTING TUBULE; KIDNEY DISTAL TUBULE; KIDNEY PARENCHYMA; KIDNEY PROXIMAL TUBULE; MALE; MOUSE; NONHUMAN; PEROXISOME; PROTEIN ANALYSIS; ANIMALS; ARISTOLOCHIACEAE; CHEMISTRY; DIAGNOSTIC USE; IMMUNOLOGY; KIDNEY; KIDNEY TUBULES, PROXIMAL; METABOLISM; METHODS; MICE, INBRED BALB C; MICROSCOPY, IMMUNOELECTRON; MITOCHONDRIA; PEROXISOMES; TISSUE DISTRIBUTION;

ANIMALS; ANTIBODIES, MONOCLONAL; ARISTOLOCHIACEAE; ARISTOLOCHIC ACIDS; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY TUBULES, PROXIMAL; MALE; MICE, INBRED BALB C; MICROSCOPY, IMMUNOELECTRON; MITOCHONDRIA; PEROXISOMES; TISSUE DISTRIBUTION;

EID: 84929314589     PISSN: 0192415X     EISSN: 17936853     Source Type: Journal    
DOI: 10.1142/S0192415X14500918     Document Type: Article

References (47)

1. Arlt, V.M., M. Stiborova and H.H. Schmeiser. Aristolochic acid as a probable huma n cancer hazard in herbal remedies: A review. Mutagenesis 17: 265-277, 2002.
2. Babu, E., M. Takeda, R. Nishida, R. Noshiro-Kofuji, M. Yoshida, S. Ueda, T. Fukutomi, N. Anzai and H. Endou. Interactions of human organic anion transporters with aristolochic acids. J. Pharmacol. Sci. 113: 192-196, 2010.
3. Chan, W., H. Luo, Y. Zheng, Y. Cheng and Z. Cai. Investigation of the metabolism and reductive activation of carcinogenic aristolochic acids in rats. Drug Metab. Dispos. 35: 866-874, 2007.
4. Chan, W., L. Cui, G. Xu and Z. Cai. Stu dy of the phase I and phase II metabolism of nephrotoxin aristolochic acid by liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 20: 1755-1760, 2006.
5. Chang, C.H., Y.M. Wang, A.H. Y ang and S.S. Chiang. Rapidly progressive interstitial renal fibrosis associated with Chinese herbal medications. Am. J. Nephrol. 21: 441-448, 2001.
6. Chen, H.Y., B.Y. Ma, A. Grant and N. Lampert. Time to abandon the term " Chinese herbs nephropathy" . Kidney Int. 60: 2039-2040, 2001.
7. Chen, Y.Y., J.G. Chung, H.C. Wu, D.T. Bau, K.Y. Wu, S.T. Kao, C.Y. Hsiang, T.Y. Ho and S.Y. Chiang. Aristolochic acid suppresses DNA repair and triggers oxidative DNA damage in human kidney proximal tubular cells. Oncol. Rep. 24: 141-153, 2010.
8. Cosyns, J.P. When is "aristolochic acid nephropathy " more accurate than "Chinese herbs nephropathy"? Kidney Int. 61: 1178, 2002.
9. Cosyns, J.P., J.P. Dehoux, Y. Guiot, R.M. Goebbels, A. Robert, A.M. Bernard and D.S.C. Van Y persele. Chronic aristolochic acid toxicity in rabbits: A model of Chinese herbs nephropathy? Kidney Int. 59: 2164-2173, 2001.
10. Cosyns, J.P., M. Jadoul, J.P. Squifflet, J.F. De Plaen, D. Ferluga and D.S.C. Van Ypersele. Chinese herbs nephropathy: A clue to Balkan endemic nephropathy? Kidney Int. 45: 1680-1688, 1994.
11. De Roe, C., P.J. Courtoy and P. Baudhuin. A model of protein-colloid al gold interactions. J. Histochem. Cytochem. 35: 1191-1198, 1987.
12. Debelle, F.D., J. Vanherweghem and J.L. Nortier. Aristolochic acid nephropathy: A worldwide problem. Kidney Int. 74: 158-169, 2008.
13. Debelle, F.D., J.L. Nortier, E.G. De Prez, C.H. Garbar, A.R. Vienne, I.J. Salmon, M.M. Deschodt-Lanckman and J. Vanherweghem. Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats. J. Am. Soc. Nephrol. 13: 431-436, 2002.
14. Depierreux, M., B. Van Damme, H.K. Vanden and J.L. Vanherweghem. Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. Am. J. Kidney Dis. 24: 172-180, 1994.
15. Dickman, K.G., D.H. Sweet, R. Bonala, T. Ray and A. Wu. Physiological and molecular characterization of aristolochic acid transport by the kidney. J. Pharmacol. Exp. Ther. 338: 588-597, 2011.
16. Gu, L., N. Li, W. Yu, J. Gong, Q. Li, W. Zhu and J. Li. Berberine reduces rat intestinal tight junction injury induced by ischemia-reperfusion associated with the suppression of inducible nitric oxide synthesis. Am. J. Chin. Med. 41: 1297-1312, 2013.
17. Heinrich, M., J. Chan, S. Wanke, C. Neinhuis and M.S.J. Simmonds. Local uses of Aristolochia species and content of nephrotoxic aristolochic acid 1 and 2-A global assessment based on bibliographic sources. J. Et hnopharmacol. 125: 108-144, 2009.
18. Krumbiegel, G., J. Hallensleben, W.H. Mennicke, N. Rittmann and H.J. Roth. Studies on the metabolism of aristolochic acids I and II. Xenobiotica 17: 981-991, 1987.
19. Kumar V. Poonam A.K. Prasad V.S. Parmar Naturally occurring aristolactams, aristolochic acids and dioxoaporphines and their biological activities. Nat. Prod. Rep. 20 565-583 2003.
20. Li, X.W., O. Morinaga, M. Tian, T. Uto, J. Yu, M.Y. Shang, X. Wang, S.Q. Cai and Y. Shoyama. Development of an Eastern blotting technique for the visual detection of aristolochic acids in aristolochia and asarum species by using a monoclonal antibody against aristolochic acids I and II. Phytochem. Anal. 24: 645-653, 2013.
21. Liu, Y., H. Zhao, J. Zhang, P. Zhang, M. Li, F. Qi, Y. Wang, S. Kou, Q. Zheng and L. Wang. The regulatory effect of liuwei dihuang pills on cytokines in mice with experimental autoimmune encephalomyelitis. Am. J. Chin. Med. 40: 295-308, 2012.
22. Lou, Y., J. Li, Y. Lu, X. Wang, R. Jiao, S. Wang and L. Kong. Aristolochic acid-induced destruction of organic ion transporters and fatty acid metabolic disorder in the kidney of rats. Toxicol. Lett. 201: 72-79, 2011.
23. Mengs, U. Acute toxicity of aristolochic acid in rodents. Arch. Toxicol. 59: 328-331, 1987.
24. Mengs, U. and C.D. Stotzem. Toxicity of aristolochic acid. A subacute study in male rats. Med. Sci. Res. 20: 223-224, 1992.
25. Parsons, M., T. Furuya, S. Pal and P. Kessler. Biogenesis and function of peroxisomes and glycosomes. Mol. Biochem. Parasit. 115: 19-28, 2001.
26. Pozdzik, A.A., A. Berton, H.H. Schmeiser, W. Missoum, C. Decaestecker, I.J. Salmon, J.L. Vanherweghem and J.L. Nortier. Aristolochic acid nephropathy revisited: A place for innate and adaptive immunity? Histopathology 56: 449-463, 2010.
27. Pozdzik, A.A., I.J. Salmon, F.D. Debelle, C. Decaestecker, C. Van den Branden, D. Verbeelen, M.M. Deschodt-Lanckman, J.L. Vanherweghem and J.L. Nortier. Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation. Kidney Int. 73: 595-607, 2008.
28. Priestap, H.A., M.C . Torres, R.A. Rieger, K.G. Dickman, T. Freshwater, D.R. Taft, M.A. Barbieri and C.R. Iden. Aristolochic Acid I metabolism in the isolated perfused rat kidney. Chem. Res. Toxicol. 25: 130-139, 2012.
29. Qi, X., Y. Cai, L. Gong, L. Liu, F. Chen, Y. Xiao, X. Wu, Y. Li, X. Xue and J. Ren. Role of mitochondrial permeability transition in human renal tubular epithelial cell death induced by aristolo chic acid. Toxicol. Appl. Pharmacol. 222: 105-110, 2007.
30. Romanov, V., T. Whyard, R. Bonala, F. Johnson and A. Grollman. Glutamate dehydrogenase requirement for apoptosis induced by aristolochic acid in renal tubular epithelial cells. Apoptosis 16: 1217-1228, 2011.
31. Rosenquist, T.A., H.J. Einolf, K.G. Dickman, L. Wang, A. Smith and A.P. Grollman. Cytochrome P 450 1A2 detoxicates aristolochic acid in the mouse. Drug Metab. Dispos. 38: 761-768, 2010.
32. Sato, N., D. Takahashi, S. Chen, R. Tsuchiya, T. Mukoyama, S. Yamagata, M. Ogawa, M. Yoshida, S. Kondo, N. Satoh and S. Ueda. Acute nephrotoxicity of aristolochic acids in mice. J. Pharm. Pharmacol. 56: 221-229, 2004.
33. Shi, H. and J.M. Feng. Aristolochic acid induces apoptosis of human umbilical vein endothelial cells in vitro by suppressing PI3K/Akt signaling pathway. Acta Pharmacol. Sin. 32: 1025-1030, 2011.
34. Shibutani, S., H. Dong, N. Suzuki, S. Ueda, F. Miller and A.P. Grollman. Selective toxicity of aristolochic acids I and II. Drug Metab. Dispos. 35: 1217-1222, 2007.
35. Shibutani, S., R.R. Bonala, T. Rosenquist, R. Rieger, N. Suzuki, F. Johnson, F. Miller and A.P. Grollman. Detoxification of aristolochic acid I by O-demethylation: Less nephrotoxicity and genotoxicity of aristolochic acid Ia in rodents. Int. J. Cancer 127: 1021-1027, 2010.
36. Stiborova, M., E. Frei, V.M. Arlt and H.H. Schmeiser. Metabolic activation of carcinogenic aristolochic acid, a risk factor for Balkan endemic nephropathy. Mutat. Res. 658: 55-67, 2008.
37. Tian, M., H. Tanaka, M.Y. Shang, S. Karashima, Z. Chao, X. Wang, S.Q. Cai and Y. Shoyama. Production, characterization of a monoclonal antibody against aristolochic ac id-II and development of its assay system. Am. J. Chin. Med. 36: 425-436, 2008.
38. Wanders, R.J., J.P. Ruiter, L. IJLst, H.R. Waterham and S.M. Houten. The enzymology of mitochondrial fatty acid b eta-oxidation and its application to follow-up analysis of positive neonatal screening results. J. Inherit. Metab. Dis. 33: 479-494, 2010.
39. Weibel, E.R., G.S. Kistler, W.F. Scherle, Practical stereological methods for morphometric cytology. J. Cell Biol. 30: 23-38, 1966.
40. Weinberg, J. Lipotoxicity. Kidney Int. 70 1560-1566 2006.
41. Xing, G., X. Qi, M. C hen, Y. Wu, J. Yao, L. Gong, T. Nohmi, Y. Luan and J. Ren. Comparison of the mutagenicity of aristolochic acid I and aristolochic acid II in the gpt delta transgenic mouse kidney. Mutat. Res. 743: 52-58, 2012.
42. Xu, W., K. Chu, H. Li, Y. Zhang, M. Huang, H. Zheng, M. Sha, X. Zhang and L. Chen. Bauhinia championii extraction treatment of collagen-induced arthritis via downregulation of the express ion of TLR4, MyD88 and NF-kappaB. Am. J. Chin. Med. 41: 379-390, 2013.
43. Xue, X., L.K. Gong, K. Maeda, Y. Luan, X.M. Qi, Y. Sugiyama and J. Ren. Critical role of organic anion transporters 1 and 3 in kidney accumulation and toxicity of aristolochic Acid I. Mol. Pharm. 8: 2183-2192, 2011.
44. Yang, H., Y. Dou, X. Zheng, Y. Tan, J. Cheng, L. Li, Y. Du, D. Zhu and Y. Lou. Cysteinyl leukotrienes synthesis is involved in aristolochic acid I-induced apoptosis in renal proximal tubular epithelial cells. Toxicology 287: 38-45, 2011.
45. Yeh, Y., Y. Lee, H. Hsieh and D. Hwang. Short-term toxicity of aristolochic acid, aristolochic acid-I and aristolochic acid-II in rats. Food Chem. Toxicol. 46: 1157-1163, 2008.
46. Y u, F.Y., T.S. Wu, T.W. Chen and B.H. Liu. Aristolochic acid I induced oxidative DNA damage associated with glutathione depletion and ERK1/2 activation in human cells. Toxicol. In Vitro 25: 810-816, 2011.
47. Zeng, Y., R. Zhang, J. Wu, M. Liu, W. Peng, X. Yu and X. Yang. Organic anion transporter 1 (OAT1) involved in renal cell transport of aristolochic acid I. Hum. Exp. Toxicol. 2011. DOI: 10.1177/0960327111424302.